Loading…

Serum S100B Determination in the Management of Pediatric Mild Traumatic Brain Injury

The place of serum S100B measurement in mild traumatic brain injury (mTBI) management is still controversial. Our prospective study aimed to evaluate its utility in the largest child cohort described to date. Children younger than 16 years presenting at a pediatric emergency department within 3 h af...

Full description

Saved in:
Bibliographic Details
Published in:Clinical chemistry (Baltimore, Md.) Md.), 2012-07, Vol.58 (7), p.1116-1122
Main Authors: BOUVIER, Damien, FOURNIER, Mathilde, DAUPHIN, Jean-Benoît, AMAT, Flore, UGHETTO, Sylvie, LABBE, André, SAPIN, Vincent
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The place of serum S100B measurement in mild traumatic brain injury (mTBI) management is still controversial. Our prospective study aimed to evaluate its utility in the largest child cohort described to date. Children younger than 16 years presenting at a pediatric emergency department within 3 h after TBI were enrolled prospectively for blood sampling to determine serum S100B concentrations. The following information was collected: TBI severity determined by using the Masters classification [1: minimal or Glasgow Coma Scale (GCS) 15, 2: mild or GCS 13-15, and 3: severe or GCS
ISSN:0009-9147
1530-8561
DOI:10.1373/clinchem.2011.180828